Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$25.3M Sell
158,675
-20,742
-12% -$3.47M 0.02% 808
2014
Q2
$31.2M Buy
179,417
+10,701
+6% +$1.6M 0.02% 650
2014
Q1
$24.4M Sell
168,716
-45,779
-21% -$6.73M 0.02% 698
2013
Q4
$23.1M Buy
214,495
+22,527
+12% +$2.06M 0.02% 718
2013
Q3
$15.1M Buy
191,968
+44,570
+30% +$3.41M 0.02% 856
2013
Q2
$10.7M Buy
+147,398
New +$9.43M 0.01% 991

Other funds holding ILMN

UBS's ILMN Position: Q3 2014 in Review

UBS reduced its Illumina (ILMN) stake by 12% in Q3 2014, selling an estimated $3.47M and leaving 158,675 shares worth $25.3M. The position accounts for 0.02% of the portfolio, ranked #808.

UBS first reported a position in ILMN in Q2 2013 and has held it in 6 quarters since. The position peaked at $31.2M in Q2 2014. 480 funds tracked by Wall St. Rank hold ILMN as of Q3 2014.

  • UBS held 158,675 shares of Illumina worth $25.3M as of Q3 2014.
  • UBS sold 20,742 Illumina shares in Q3 2014, an estimated $3.47M.
  • Illumina made up 0.02% of UBS's portfolio in Q3 2014, its #808 holding.
  • UBS first reported a position in Illumina in Q2 2013 and has held it in 6 quarters since.
  • UBS's Illumina position peaked at $31.2M in Q2 2014.
  • 480 funds tracked by Wall St. Rank held Illumina as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.